Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3

被引:28
作者
Robertson, LA
Kim, AJ
Werstuck, GH [1 ]
机构
[1] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8V 1C3, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada
[3] McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada
关键词
diabetes mellitus; atherosclerosis; endoplasmic reticulum stress; GSK-3; hexosamine pathway;
D O I
10.1139/Y05-142
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent decades have seen a significant increase in the incidence of diabetes mellitus. The number of individuals with diabetes is projected to reach 300 million by the year 2025. Diabetes is a leading cause of blindness, renal failure, lower limb amputation, and an independent risk factor for atherosclerotic cardiovascular disease (CVD) - a leading cause of death in Western society. Understanding the molecular and cellular mechanisms by which diabetes mellitus promotes atherosclerosis is essential to developing methods to treat and prevent diabetes-associated CVD. This review summarizes our current knowledge of the mechanisms by which diabetes may promote atherogenesis and specifically focuses on a novel pathway linking these 2 conditions. We hypothesize that the accumulation of intracellular glucosarnine observed in conditions of chronic hyperglycaemia may promote atherogenesis via a mechanism involving dysregulated protein folding, activation of encloplasmic reticulum (ER) stress, and increased glycogen synthase kinase (GSK)-3 activity. The identification of this novel mechanism provides a promising hypothesis and multiple new targets for potential therapeutic intervention in the treatment of diabetes mellitus and accelerated atherosclerosis.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 96 条
[61]   Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes [J].
Özcan, U ;
Cao, Q ;
Yilmaz, E ;
Lee, AH ;
Iwakoshi, NN ;
Özdelen, E ;
Tuncman, G ;
Görgün, C ;
Glimcher, LH ;
Hotamisligil, GS .
SCIENCE, 2004, 306 (5695) :457-461
[62]  
PENRY JK, 1989, J CLIN PSYCHIAT, V50, P17
[63]  
Peppa M., 2003, CLIN DIABETES, V21, P186, DOI [DOI 10.2337/DIACLIN.21.4.186, 10.2337/diaclin.21.4.186]
[64]   GSK-3α regulates production of Alzheimer's disease amyloid-β peptides [J].
Phiel, CJ ;
Wilson, CA ;
Lee, VMY ;
Klein, PS .
NATURE, 2003, 423 (6938) :435-439
[65]   Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells [J].
Ramana, KV ;
Friedrich, B ;
Tammali, R ;
West, MB ;
Bhatnagar, A ;
Srivastava, SK .
DIABETES, 2005, 54 (03) :818-829
[66]   Enzymes with molecular tunnels [J].
Raushel, FM ;
Thoden, JB ;
Holden, HM .
ACCOUNTS OF CHEMICAL RESEARCH, 2003, 36 (07) :539-548
[67]   Binding of GSK3 beta to the APC-beta-catenin complex and regulation of complex assembly [J].
Rubinfeld, B ;
Albert, I ;
Porfiri, E ;
Fiol, C ;
Munemitsu, S ;
Polakis, P .
SCIENCE, 1996, 272 (5264) :1023-1026
[68]   A trip to the ER: coping with stress [J].
Rutkowski, DT ;
Kaufman, RJ .
TRENDS IN CELL BIOLOGY, 2004, 14 (01) :20-28
[69]  
SAKSELA K, 1992, ONCOGENE, V7, P347
[70]   ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of golgi localization signals [J].
Shen, JS ;
Chen, X ;
Hendershot, L ;
Prywes, R .
DEVELOPMENTAL CELL, 2002, 3 (01) :99-111